269 related articles for article (PubMed ID: 33596468)
1. Antimicrobial susceptibility testing of Eggerthella lenta blood culture isolates at a university hospital in Belgium from 2004 to 2018.
Declerck B; Van der Beken Y; De Geyter D; Piérard D; Wybo I
Anaerobe; 2021 Jun; 69():102348. PubMed ID: 33596468
[TBL] [Abstract][Full Text] [Related]
2. Eggerthella lenta Bloodstream Infections Are Associated With Increased Mortality Following Empiric Piperacillin-Tazobactam (TZP) Monotherapy: A Population-based Cohort Study.
Ugarte-Torres A; Gillrie MR; Griener TP; Church DL
Clin Infect Dis; 2018 Jul; 67(2):221-228. PubMed ID: 29373647
[TBL] [Abstract][Full Text] [Related]
3. Clinical and microbiological characteristics of Eggerthella lenta bacteremia.
Gardiner BJ; Tai AY; Kotsanas D; Francis MJ; Roberts SA; Ballard SA; Junckerstorff RK; Korman TM
J Clin Microbiol; 2015 Feb; 53(2):626-35. PubMed ID: 25520446
[TBL] [Abstract][Full Text] [Related]
4. Microbiological diagnosis of Eggerthella lenta blood culture isolates in a Swedish tertiary hospital: Rapid identification and antimicrobial susceptibility profile.
Liderot K; Ratcliffe P; Lüthje P; Thidholm E; Özenci V
Anaerobe; 2016 Apr; 38():21-24. PubMed ID: 26612006
[TBL] [Abstract][Full Text] [Related]
5.
Bo J; Wang S; Bi Y; Ma S; Wang M; Du Z
Future Microbiol; 2020 Jul; 15():981-985. PubMed ID: 32815419
[No Abstract] [Full Text] [Related]
6. Identification and Antibiotic Susceptibility of
Li X; Xu E; Shi C; Qiao G; Chen S; Xu Y; Liu Y; Bao X
Pol J Microbiol; 2022 Jun; 71(2):257-261. PubMed ID: 35716165
[TBL] [Abstract][Full Text] [Related]
7. Clinical and microbiological characteristics of Eggerthella lenta bacteremia at a Japanese tertiary hospital.
Nagaoka R; Kitagawa H; Koba Y; Tadera K; Hara T; Kashiyama S; Nomura T; Omori K; Shigemoto N; Yokozaki M; Ohge H
J Infect Chemother; 2021 Aug; 27(8):1261-1264. PubMed ID: 33853729
[TBL] [Abstract][Full Text] [Related]
8. [Antimicrobial Susceptibility of Pathogenic Gram-positive Anaerobic Cocci: Data of a University Hospital in Turkey].
Akgül Ö; Söyletir G; Ülger Toprak N
Mikrobiyol Bul; 2020 Jul; 54(3):404-417. PubMed ID: 32755517
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial susceptibility of clinically isolated anaerobic bacteria in a University Hospital Centre Split, Croatia in 2013.
Novak A; Rubic Z; Dogas V; Goic-Barisic I; Radic M; Tonkic M
Anaerobe; 2015 Feb; 31():31-6. PubMed ID: 25479237
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial susceptibility patterns of clinically significant Gram-positive anaerobic bacteria in a Greek tertiary-care hospital, 2017-2019.
Maraki S; Mavromanolaki VE; Stafylaki D; Kasimati A
Anaerobe; 2020 Aug; 64():102245. PubMed ID: 32707228
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial susceptibility of clinical isolates of anaerobic bacteria in Ontario, 2010-2011.
Marchand-Austin A; Rawte P; Toye B; Jamieson FB; Farrell DJ; Patel SN
Anaerobe; 2014 Aug; 28():120-5. PubMed ID: 24923267
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial susceptibility profiles of invasive isolates of anaerobic bacteria from a large Canadian reference laboratory: 2012-2019.
Forbes JD; Kus JV; Patel SN
Anaerobe; 2021 Aug; 70():102386. PubMed ID: 34044100
[TBL] [Abstract][Full Text] [Related]
13. Fourth Belgian multicentre survey of antibiotic susceptibility of anaerobic bacteria.
Wybo I; Van den Bossche D; Soetens O; Vekens E; Vandoorslaer K; Claeys G; Glupczynski Y; Ieven M; Melin P; Nonhoff C; Rodriguez-Villalobos H; Verhaegen J; Piérard D
J Antimicrob Chemother; 2014 Jan; 69(1):155-61. PubMed ID: 24008826
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial susceptibility and clinical findings of significant anaerobic bacteria in southern Spain.
Cobo F; Rodríguez-Granger J; Pérez-Zapata I; Sampedro A; Aliaga L; Navarro-Marí JM
Anaerobe; 2019 Oct; 59():49-53. PubMed ID: 31103531
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial Susceptibility Patterns of Anaerobic Bacterial Clinical Isolates From 2014 to 2016, Including Recently Named or Renamed Species.
Byun JH; Kim M; Lee Y; Lee K; Chong Y
Ann Lab Med; 2019 Mar; 39(2):190-199. PubMed ID: 30430782
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics and antimicrobial susceptibilities of anaerobic bacteremia in an acute care hospital.
Tan TY; Ng LS; Kwang LL; Rao S; Eng LC
Anaerobe; 2017 Feb; 43():69-74. PubMed ID: 27890724
[TBL] [Abstract][Full Text] [Related]
17. Anaerobic blood culture isolates in a Norwegian university hospital: identification by MALDI-TOF MS vs 16S rRNA sequencing and antimicrobial susceptibility profiles.
Handal N; Bakken Jørgensen S; Smith Tunsjø H; Johnsen BO; Leegaard TM
APMIS; 2015 Sep; 123(9):749-58. PubMed ID: 26123879
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial susceptibility of anaerobic bacteria in Belgium as determined by E-test methodology.
Glupczynski Y; Berhin C; Nizet H
Eur J Clin Microbiol Infect Dis; 2009 Mar; 28(3):261-7. PubMed ID: 18797943
[TBL] [Abstract][Full Text] [Related]
19. Eggerthella lenta as a cause of anaerobic spondylodiscitis.
Bok CW; Ng YS
Singapore Med J; 2009 Dec; 50(12):e393-6. PubMed ID: 20087537
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of tigecycline and comparators against a European collection of anaerobes collected as part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) 2010-2016.
Rodloff AC; Dowzicky MJ
Anaerobe; 2018 Jun; 51():78-88. PubMed ID: 29679648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
